Medicines for Malaria Venture (MMV) - Articles and news items

Novartis and MMV expand partnership to develop KAF156

Industry news / 15 June 2016 / Victoria White, Digital Content Producer

Novartis’ KAF156 is one of the first antimalarial drug candidates to enter Phase IIb clinical development in more than 20 years…


Sanofi extends collaboration with Medicines for Malaria Venture

Industry news / 8 July 2015 / Victoria White

Sanofi is to extend its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new single, fixed-dose combination therapy for malaria…

GlaxoSmithKline logo

GSK and MMV announce start of phase III programme of tafenoquine for Plasmodium vivax malaria

Industry news / 28 April 2014 / GlaxoSmithKline

GlaxoSmithKline and Medicines for Malaria Venture announced the start of a phase III global programme to evaluate the efficacy and safety of tafenoquine…

Sanofi Aventis logo

Sanofi-aventis and Medicines for Malaria Venture join forces to develop innovative malaria drugs

Industry news, News / 5 May 2011 / Sanofi-Aventis

Sanofi-aventis and MMV announced that they have signed an alliance agreement…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...